Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Auditor change
Credit agrmnt [a]
Director departure
Employment agrmnt
|
|
HORIZON PHARMACEUTICAL LLC (RPTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/20/2019 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 02/01/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 02/21/2017 |
SC 13G/A
| Credit Suisse Trust Ltd reports a 0% stake in Horizon Pharmaceutical LLC |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/13/2017 |
SC 13G/A
| Credit Suisse Trust Ltd reports a 5.1% stake in Raptor Pharmaceutical Corporation |
| 11/04/2016 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 10/31/2016 |
8-K
| Quarterly results |
| 10/31/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/31/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/31/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/31/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/31/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/26/2016 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Happel David (Chief Commercial Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Smith Michael P (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Gould Ashley C. (Chief Legal Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Anderson Raymond (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Smith Julie (President and CEO) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Keltner Llew (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| FRANKLIN RICHARD L (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Unknown transaction of 6,695 shares
@ $9, valued at
$60.3k
Disposed/sold 8,330 shares
@ $9, valued at
$75k
Disposed/sold 90,000 options to buy
@ $3.54, valued at
$318.6k
Disposed/sold 120,000 options to buy
@ $5.13, valued at
$615.6k
Disposed/sold 50,000 options to buy
@ $5.49, valued at
$274.5k
|
|
| 10/26/2016 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/26/2016 |
4
| Polu Krishna R (Chief Medical Officer) has filed a Form 4 on Raptor Pharmaceutical Corp |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
|
|
|